Market Currents
NPS Pharmaceuticals (NPSP +1.8%) trades higher after the FDA accepts its Gattex drug application...
-
Tuesday, January 31, 2012, 9:46 AM ETNPS Pharmaceuticals (NPSP +1.8%) trades higher after the FDA accepts its Gattex drug application for review. Slicing through the firm's statement a bit - it appears that it didn't land a coveted "priority" review from the FDA.
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
